9298436 Canada Inc.: federal grants and contributions

Updated 12 October 2026 · Laval, QC · grants and contributions register · Lac-Saint-Louis

9298436 Canada Inc.: federal grants and contributions: 2 agreements; $3.9M value; 2 departments; 2 programs.

Assay record ASY-CA-1EDP5YO1DU · Cite as: Assay Systems, “9298436 Canada Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/9298436-canada-inc/

$
2agreements
$3.9Mvalue
2departments
2programs

Largest agreements

COVID-19 Response (VI): Nasal Vaccine Development$2.9Mvalue2020start2021end

Development of a Nasal Vaccine for the prevention of coronavirus disease 2019 due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).

400057068$1.0Mvalue2020start2022end

Equipment Acquisition: The project aims to increase the competitiveness and expansion of a company specializing in contract research services for drug discovery.

Departments

National Research Council Canada1agreements$2.9Mvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms

All grants from National Research Council Canada

Canada Economic Development for Quebec Regions1agreements$1.0Mvalue1programs
  • Regional Economic Growth through Innovation Program (REGI)

All grants from Canada Economic Development for Quebec Regions

Years

20202agreements$3.9Mvalue2programs
  • Industrial Research Assistance Program – Contributions to Firms
  • Regional Economic Growth through Innovation Program (REGI)

Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.